Three More Juul Vaping Products Clear Federal Review with Less Nicotine Than the Versions Approved Last Year
Summary
Federal regulators have authorized three more Juul products for U.S. sale, featuring nicotine concentrations roughly half that of previously approved versions. The decision, made through the premarket tobacco product application pathway, covers the Juul2 device with tobacco and menthol-flavored pods. Regulators emphasized that authorization is not a safety endorsement but a determination that population health benefits outweigh risks, primarily considering adult smokers who might switch from cigarettes. Company data showed that 19.9% to 49.3% of users had completely stopped smoking at six weeks, but dual use (smoking and vaping together) provides less benefit. The menthol authorization was contested by the American Academy of Pediatrics, which argued it would perpetuate youth nicotine uptake, but the agency concluded adult benefits outweighed that risk. The decision highlights that only 48 e-cigarette products are federally authorized, while many unregulated products remain on shelves with potentially inaccurate labeling.
(Source:Medical Daily)